Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders?

Behavioural Brain Research

Volumn 176, Issue 1, 2007, Pages 170-186

  Carter, C Sue ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Autism; Oxytocin; Reelin; Sex differences; Testosterone; Vasopressin

Indexed keywords

ANDROGEN; ARGIPRESSIN; GROWTH FACTOR; NEUROPEPTIDE; OXYTOCIN; REELIN;

AMYGDALOID NUCLEUS; AUTISM; BEHAVIOR; BRAIN REGION; COMPULSION; DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN METABOLISM; REVIEW; SEX DIFFERENCE;

AMYGDALA; ANIMALS; ARGININE VASOPRESSIN; AUTISTIC DISORDER; FEMALE; HUMANS; MALE; OXYTOCIN; SEX FACTORS;

EID: 33845286863     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.08.025     Document Type: Review

References (245)

1. Albers H.E., Huhman K.L., and Meisel R.L. Hormonal basis of social conflict and communication. In: Pfaff D., et al. (Ed). Hormones, brain and behavior vol. 1 (2002), Academic Press, San Diego 393-434
2. Altemus M., Deuster P.A., Gallivan E., Carter C.S., and Gold P.W. Suppression of hypothalamic-pituitary-adrenal responses to exercise stress in lactating women. J Clin Endocrinol Metab 80 (1995) 2954-2959
3. Altemus M., Pigott T., Kalogeras K.T., Demitrack M., Dubbert B., Murphy D.L., et al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiat 49 (1992) 9-20
4. Altemus M., Redwine L.S., Leong Y.-M., Frye C.A., Porges S.W., and Carter C.S. Responses to laboratory psychosocial stress in postpartum women. Psychosom Med 63 (2001) 814-821
5. Amaral D.G., Bauman M.D., and Schumann C.M. The amygdala and autism: implications from non-human primate studies. Genes Brain Behav 2 (2003) 295-302
6. Appenrodt E., Schnabel R., and Schwarzberg H. Vasopressin administration modulates anxiety-related behavior in rats. Physiol Behav 64 (1998) 543-547
7. Assenza G., Biamonte F., Cesa R., Strata P., and Keller F. Interaction between reelin and estrogens on Purkinje cells during development: a model of cerebellar pathology in autism and related disorders. Soc Neurosci Abstr 251 (2005) 2
8. Auger C.J., and Vanzo R.J. Progesterone treatment of adult male rats suppresses arginine vasopressin expression in the bed nucleus of the stria terminalis and the centromedial amygdala. J Neuroendocrinol 18 (2006) 187-194
9. Bales K., and Carter C.S. Developmental exposure to oxytocin facilitates partner preferences in male prairie voles (Microtus ochrogaster). Behav Neurosci 117 (2003) 854-859
10. Bales K., and Carter C.S. Sex differences and developmental effects of oxytocin on aggression in prairie voles. Horm Behav 44 (2003) 178-184
11. Bales K., Pfeifer L., and Carter C.S. Sex differences and developmental effects of manipulations of oxytocin on anxiety and alloparenting in prairie voles. Dev Psychobiol 44 (2004) 123-131
12. Bales K.L., Kim A.J., Lewis-Reese A.D., and Carter C.S. Both oxytocin and vasopressin may influence alloparental care in male prairie voles. Horm Behav 45 (2004) 354-361
13. Bales K.L., Kramer K.M., Lewis-Reese A.D., and Carter C.S. Effects of stress on parental care are sexually dimorphic in prairie voles. Physiol Behav 87 (2006) 424-429
14. Bales KL, Plotsky PM, Young LJ, Lim MM, Grotte N, Carter CS. Neonatal oxytocin manipulations have long-lasting sexually dimorphic effects on vasopressin receptors. Neuroscience, in press.
15. Bamshad M., Novak M.A., and De Vries G.J. Sex and species differences in the vasopressin innervation of sexually naive and parental prairie voles, Microtus ochrogaster and meadow voles, Microtus pennsylvanicus. J Neuroendocrinol 5 (1993) 247-255
16. Barberis C., Mouillac B., and Durroux T. Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 156 (1998) 223-229
17. Barberis C., and Tribollet E. Vasopressin and oxytocin receptors in the central nervous system. Crit Rev Neurobiol 10 (1996) 119-154
18. Baron-Cohen S. The extreme male brain theory of autism. Trends Cognitive Sci 6 (2002) 248-254
19. Baron-Cohen S., and Belmonte M.K. Autism: a window onto the development of the social and the analytic brain. Annu Rev Neurosci 28 (2005) 109-126
20. Bauman M.L., and Kemper T.L. Neuroanatomic observations of the brain in autism. In: Bauman M.L., and Kemper T.L. (Eds). The neurobiology of autism (1994), John Hopkins University Press, Baltimore, MD 119-145
21. Bielsky I.F., Hu S.B., Ren X., Terwilliger E.F., and Young L.J. The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study. Neuron 47 (2005) 503-513
22. Bielsky I.F., Hu S.B., Szegda K.L., Westphal H., and Young L.J. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 29 (2004) 483-493
23. Bielsky I.F., Hu S.B., and Young L.J. Sexual dimorphism in the vasopressin system: lack of an altered behavioral phenotype in female V1a receptor knockout mice. Behav Brain Res 164 (2005) 132-136
24. Birnbaumer M. Vasopressin receptors. In: Pfaff D., et al. (Ed). Hormones, brain and behavior vol. III (2002), Academic Press, San Diego 803-810
25. Boccia M.L., and Pedersen C.A. Brief vs. long maternal separations in infancy: contrasting relationships with adult maternal behavior and lactation levels of aggression and anxiety. Psychoneuroendocrinology 26 (2001) 657-672
26. Boer G.J. Chronic OT treatment during late gestation and lactation impairs development of rat offspring. Neurotoxicol Teratol 15 (1993) 383-389
27. Boer G.J., Quak J., De Vries M.C., and Heinsbroek R.P.W. Mild sustained effects of neonatal AVP and OT treatment on brain growth and behavior of the rat. Peptides 15 (1994) 229-236
28. Bonora E., Lamb J.A., Barnby G., Sykes N., Moberly T., Beyer K.S., et al. International molecular genetic study of austism consortium. Eur J Hum Genet 13 (2005) 198-207
29. Bossmar T., Akerlund M., Szamatowicz J., Laudanski T., Fantoni G., and Maggi M. Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women. Br J Obstet Gynaecol 102 (1995) 907-912
30. Cameron J.L. Metabolic cues for the onset of puberty. Horm Res 36 (1991) 97-103
31. Carter C.S. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 23 (1998) 779-818
32. Carter C.S. Developmental consequences of oxytocin. Physiol Behav 79 (2003) 383-397
33. Carter C.S., and Altemus M. Integrative functions of lactational hormones in social behavior and stress management. Ann NY Acad Sci: Integrat Neurobiol Affiliation 807 (1997) 164-174
34. Carter C.S., and Keverne E.B. The neurobiology of social affiliation and pair bonding. In: Pfaff D., et al. (Ed). Hormones, brain and behavior vol. I (2002), Academic Press, San Diego 298-338
35. Carter CS, Yamamoto Y, Kramer KM, Hoffman GE, Cushing BS. Early handling produces long-lasting increases in oxytocin and alters the response to separation. Soc Neurosci Abstr; 2003.
36. Chakrabarti S., and Fombonne E. Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiat 162 (2005) 1133-1141
37. Champagne F.A., Diorio J., Sharma S., and Meaney M.J. Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc Natl Acad Sci USA 98 (2001) 12736-12741
38. Champagne F.A., and Meaney M.J. Stress during gestation alters postpartum maternal care and the development of the offspring in a rodent model. Biol Psychiatry 59 (2006) 1227-1235
39. Champagne F.A., Weaver I.C., Diorio J., Sharma S., and Meaney M.J. Natural variations in maternal care are associated with estrogen receptor alpha expression and estrogen sensitivity in the media preoptic area. Endocrinology 11 (2003) 4720-4747
40. Chen Y., Sharma R., Costa R.H., Costa E., and Grayson D.R. On the epigenetic regulation of the human reelin promoter. Nucl Acids Res 3 (2002) 2930-2939
41. Cho M.M., DeVries A.C., Williams J.R., and Carter C.S. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav Neurosci 113 (1999) 1071-1080
42. Choleris E., Kavaliers M., and Pfaff D.W. Functional genomics of social recognition. J Neuroendocrinol 16 (2004) 383-389
43. Coccaro E.F., Kavoussi R.J., Hauger R.L., Cooper T.B., and Ferris C.F. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiat 55 (1998) 708-714
44. Consiglio A.R., Borsoi A., Pereira G.A., and Lucion A.B. Effects of oxytocin microinjected into the central amygdaloid nucleus and bed nucleus of stria terminalis on maternal aggressive behavior in rats. Physiol Behav 85 (2005) 354-362
45. Cook Jr. E.H., Courchesne R.Y., Cox M.J., Lord C., Gonen D., Cuter S.J., et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 62 (1998) 1077-1083
46. Corbett B.A., Mendoza S., Abdullah M., Wegelin J.A., and Levine S. Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology 1 (2006) 59-68
47. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disab Res Rev 10 (2004) 248-258
48. Crofton J.T., Baer P.G., Share L., and Brooks D.P. Vasopressin release in male and female rats: effects of gonadectomy and treatment with gonadal steroid hormones. Endocrinology 117 (1985) 1195-1200
49. Csaba G. Receptor ontogeny and hormonal imprinting. Experentia 42 (1986) 750-759
50. DeBold C.R., Sheldon W.R., DeCherney G.S., Jackson R.V., Alexander A.N., Vale W., et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest 73 (1984) 533-538
51. Delville Y., Koh E.T., and Ferris C.F. Sexual differences in the magnocellular vasopressinergic system in golden hamsters. Brain Res Bull 33 (1994) 535-540
52. Demas G.E., Williams J.M., and Nelson R.J. Amygdala but not hippocampal lesions impair olfactory memory for mate in prairie voles (Microtus ochrogaster). Am J Physiol 273 (1997) R1683-R1689
53. DeVries G.J., and Panzica G.C. Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints. Neuroscience 138 (2006) 947-955
54. DeVries G.J., and Simerly R.B. Anatomy, development and functions of sexually dimorphic neural circuits in the mammalian brain. In: Pfaff D., et al. (Ed). Hormones, brain and behavior vol. IV (2002), Academic Press, San Diego 137-192
55. DeVries G.J., and Villalba C. Brain sexual dimorphism and sex differences in parental and other social behaviors. Ann NY Acad Sci 807 (1997) 273-286
56. DiCicco-Bloom E., Lord C., Zwaigenbaum L., Courchesne E., Dager S.R., Schmitz C., et al. The developmental neurobiology of autism spectrum disorder. J Neurosci 26 (2006) 6897-6906
57. 67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 102 (2005) 12578-12583
58. Dong H.W., and Swanson L.W. Projections from bed nuclei of the stria terminalis, anteromedial area: cerebral hemisphere integration of neuroendocrine, autonomic, and behavioral aspects of energy balance. J Comp Neurol 494 (2006) 142-178
59. Donnelly S.L., Wolpert C.M., Menold M.M., Bass M.P., Gilbert J.R., Cuccaro M.L., et al. Female with autistic disorder and monosomy X (Turner syndrome): parent-of-origin effect of the X chromosome. Am J Med Genet 96 (2000) 312-316
60. Dykens E.M., Sutcliffe J.S., and Levitt P. Autism and 15q11-q13 disorders: behavioral, genetic, and pathophysiological issues. Ment Retard Dev Disabil Res Rev 10 (2004) 284-291
61. Ebner K., Bosch O.J., Kromer S.A., Singewald N., and Neumann I.D. Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacology 30 (2005) 223-230
62. Ebner K., Wotjak C.T., Landgraf R., and Engelmann M. Neuroendocrine and behavioral response to social confrontation: residents versus intruders, active versus passive coping styles. Horm Behav 47 (2005) 14-21
63. Engelmann M., Wotjak C.T., Neumann I., Ludwig M., and Landgraf R. Behavioral consequences of intracerebral AVP and OT: focus on learning and memory. Neurosci Biobehav Rev 20 (1996) 341-358
64. Fatemi S.H. Reelin glycoprote: structure, biology and roles in health disease. Mol Psychiatry 10 (2005) 251-257
65. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22 (2002) 25-33
66. Fatemi S.H., Snow A.V., Stary J.M., Araghi-Niknam M., Reutiman T.J., Lee S., et al. Reelin signaling is impaired in autism. Biol Psychiatry 57 (2005) 777-787
67. Ferguson J.N., Young L.J., and Insel T.R. The neuroendocrine basis of social recognition. Front Neuroendocrinol 23 (2002) 200-224
68. Ferris C.F. Adolescent stress and neural plasticity in hamsters: a vasopressin-serotonin model of inappropriate aggressive behaviour. Exp Physiol 85 (2000) 85S-90S
69. Ferris CF, Lu SF, Messenger T, Guillon CD, Heindel N, Miller M, et al. Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior. Pharmacol Biochem Behav; February 24, 2006 [Epub ahead of print].
70. Ferris C.F., Stolberg T., and Delville Y. Serotonin regulation of aggressive behavior in male golden hamsters (Mesocricetus auratus). Behav Neurosci 113 (1999) 804-815
71. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disorders 33 (2003) 365-382
72. Francis D., Young L.J., Meaney M.J., and Insel T.R. Naturally occurring differences in maternal care are associated with the expression of OT and AVP (V1a) receptors: gender differences. J Neuroendocrinol 14 (2002) 349-353
73. Gatewood J.D., Wills A., Shetty S., Xu J., Arnold A.P., Burgoyne P.S., et al. Sex chromosome complement and gonadal sex influence aggressive and parental behaviors in mice. J Neurosci 26 (2006) 2335-2345
74. Geier M.R., and Geier D.A. The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med Hypotheses 64 (2005) 946-954
75. Gimpl G., and Fahrenholz F. The oxytocin receptor system: structure, function and regulation. Physiol Rev 81 (2001) 629-683
76. Gould T.D., and Gottesman I.I. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5 (2006) 113-119
77. Greaves N., Prince E., Evans D.W., and Charman T. Repetitive and ritualistic behaviour in children with Prader-Willi syndrome and children with autism. J Intellectual Disabil Res 50 (2006) 92-100
78. Green L., Fein D., Modahl C., Feinstein C., Waterhouse L., and Morris M. Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 50 (2001) 609-613
79. Grippo A.J., Kramer K.M., Carter C.S., and Porges S.W. Social isolation in prairie voles is associated with anhedonia and stress-related increases in oxytocin and vasopressin. Soc Neurosci Abstr 58 (2005) 4
80. Hadj-Sahraqui N., Frederic F., Delhayi-Bouchaud N., and Mariani J. Gender effect on Purkinje cell loss in the cerebellum of the heterozygous reeler mouse. J Neurosci 11 (1996) 45-58
81. Hammock E.A., and Young L.J. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science 308 (2005) 1630-1634
82. Hansenne I. Thymic transcription of neurohypophyseal and insulin-related genes: impact upon T-cell differentiation and self-tolerance. J Neuroendocrinol 17 (2005) 321-327
83. Haubler H.U., Jirikowski G.F., and Caldwell J.D. Sex differences among oxytocin-immunoreactive neuronal systems in the mouse hypothalamus. J Chem Neuroanat 3 (1990) 271-276
84. Heinrichs M., Baumgartner T., Kirschbaum C., and Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54 (2003) 1389-1398
85. Heinrichs M., Meinlschmidt G., Neumann I., Wagner S., Kirschbaum C., Ehlert U., et al. Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women. J Clin Endocrinol Metab 86 (2001) 4798-4804
86. Herman J.P., Ostrander M.M., Mueller N.K., and Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1201-1213
87. Hirasawa M., Mouginot D., Kozoriz M.G., Kombian S.B., and Pittman Q.J. Vasopressin differentially modulates non-NMDA receptors in vasopressin and oxytocin neurons in the supraoptic nucleus. J Neurosci 23 (2003) 4270-4277
88. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 28 (2003) 193-198
89. Holst S., Uvnas-Moberg K., and Petersson M. Postnatal oxytocin treatment and postnatal stroking of rats reduce blood pressure in adulthood. Auton Neurosci 99 (2002) 85-90
90. Hoybye C., Barkeling B., Espelund U., Petersson M., and Thoren M. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment. Growth Horm IGF Res 13 (2003) 322-327
91. Huber D., Veinante P., and Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 308 (2005) 245-248
92. Insel T.R., and Hulihan T.J. A gender-specific mechanism for pair bonding: oxytocin and partner preference formation in monogamous voles. Behav Neurosci 109 (1995) 782-789
93. Insel T.R., O'Brien D.J., and Leckman J.F. Oxytocin, vasopressin, and autism: is there a connection?. Biol Psychiatry 45 (1999) 145-157
94. Insel T.R., and Shapiro L.E. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc Natl Acad Sci USA 89 (1992) 5981-5985
95. Insel T.R., and Winslow J.T. Central administration of OT modulates the infant rat's response to social isolation. Eur J Pharmacol 203 (1991) 149-152
96. Insel T.R., and Young L.J. The neurobiology of attachment. Nat Rev Neurosci 2 (2001) 129-136
97. Insel T.R., Young L., Witt D.M., and Crews D. Gonadal steroids have paradoxical effects on brain oxytocin receptors. J Neuroendocrinol 5 (1993) 619-628
98. Iseri S.O., Sener G., Saglam B., Gedik N., Ercan F., and Yegen B.C. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res 126 (2005) 73-81
99. Ishunina T.A., and Swaab D.F. Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: size changes in relation to age and sex. J Clin Endocrinol Metab 84 (1999) 4637-4644
100. Jacob S, Brune CW, Carter CS, Leventhal B, Lord C, Cook EH, Jr. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism, unpublished manuscript.
101. Kajantie E., and Phillips D.I. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 31 (2006) 151-178
102. Khan A., Brodhead A.E., Schwartz K.A., Kolts R.L., and Brown W.A. Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 5 (2005) 318-324
103. Kim S.J., Young L.J., Gonen D., Veenstra-VanderWeele J., Courchesne R., Courchesne E., et al. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol Psychiatry 7 (2002) 503-507
104. Kimura T., Saji F., Nishimori K., Ogita K., Nakamura H., Koyama M., et al. Molecular regulation of the oxytocin receptor in peripheral organs. J Mol Endocrinol 30 (2003) 109-115
105. Kirkpatrick B., Carter C.S., Newman S.W., and Insel T.R. Axon-sparing lesions of the medial amygdala decrease affiliative behaviors in the prairie vole (Microtus ochrogaster): behavioral and anatomical specificity. Behav Neurosci 108 (1994) 501-513
106. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25 (2005) 11489-11493
107. Kolevzon A., Mathewson K.A., and Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry 67 (2006) 407-414
108. Koolhaas J.M., Everts H., de Ruiter A.J., de Boer S.F., and Bohus B. Coping with stress in rats and mice: differential peptidergic modulation of the amygdala-lateral septum complex. Prog Brain Res 119 (1998) 437-448
109. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., and Fehr E. Oxytocin increases trust in humans. Nature 435 (2005) 673-676
110. Kramer K.M., Cushing B.S., and Carter C.S. Developmental effects of oxytocin on stress response: single vs. repeated exposure. Physiol Behav 79 (2003) 775-782
111. Kramer K.M., Cushing B.S., Carter C.S., Wu J., and Ottinger M.A. Sex and species differences in plasma oxytocin using an enzyme immunoassay. Can J Zool 82 (2004) 1194-1200
112. Landgraf R. The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets 5 (2006) 167-179
113. Landgraf R., Malkinson T., Horn T., Veale W.L., Lederis K., and Pittman Q.J. Release of vasopressin and oxytocin by paraventricular stimulation in rats. Am J Physiol 258 1 Pt 2 (1990) R155-R159
114. Landgraf R., and Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25 (2004) 150-176
115. Landgraf R., and Wigger A. Born to be anxious: Neuroendocrine and genetic correlates of trait anxiety in HAB rats. Stress 6 (2003) 111-119
116. Landry M., Frasier M., Chen Z., Van De Kar L.D., Zhang Y., Garcia F., et al. Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin. Synapse 58 (2005) 102-109
117. Leckman J.F., Goodman W.K., North W.G., Chappell P.B., Price L.H., Pauls D.L., et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology 19 (1994) 723-749
118. Leckman J.F., Goodman W.K., North W.G., Chappell P.B., Price L.H., Pauls D.L., et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiat 51 (1994) 782-792
119. Leckman J.F., and Herman A.E. Maternal behavior and developmental psychopathology. Biol Psychiatry 51 (2002) 27-43
120. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., and Koenig J.I. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30 (2005) 1883-1894
121. Light K.C., Grewen K.M., Amico J.A., Brownley K.A., West S.G., Hinderliter A.L., et al. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement. Horm Behav 47 (2005) 540-548
122. Lim M.M., Bielsky I.F., and Young L.J. Neuropeptides and the social brain: potential rodent models of autism. Int J Dev Neurosci 23 (2005) 235-243
123. Lim M.M., Wang Z., Olazabal D.E., RenX, Terwilliger E.F., and Young L.J. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature 42 (2004) 754-757
124. Lipari E.F., Lipari D., Gerbino A., Di Liberto D., Bellafiore M., Catalano M., et al. The hypothalamic magnocellular neurosecretory system in developing rats. Eur J Histochem 45 (2001) 163-168
125. Liu W.-S., Pappas G.D., and Carter C.S. Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/-) reeler mice. Neurol Res 27 (2005) 1-8
126. Liu W.-S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lacor P., et al. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc Natl Acad Sci USA 98 (2001) 3477-3482
127. Lolait S.J., O'Carroll A.M., Mahan L.C., Felder C.C., Button D.C., Young III W.S., et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA 92 (1995) 6783-6787
128. Lord C., Leventhal B.L., and Cook Jr. E.H. Quantifying the phenotype in autism spectrum disorders. Am J Med Genet 105 (2001) 36-38
129. Lutchmaya S., Baron-Cohen S., Raggatt P., Knickmeyer R., and Manning J.T. 2nd to 4th digit ratios, fetal testosterone and estradiol. Early Hum Dev 77 (2004) 23-28
130. Machado C.J., and Bachevalier J. Non-human primate models of childhood psychopathology: the promise and the limitations. J Child Psychol Psychiatry 4 (2003) 64-87
131. Maes M., Goossens F., Lin A., De Meester I., Van Gastel A., and Scharpe S. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety. Psychoneuroendocrinology 23 (1998) 485-495
132. Maes M., Lin A.H., Bonaccorso S., Goossens F., Van Gastel A., Pioli R., et al. Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder. J Affective Disord 53 (1999) 27-34
133. Maes M., Monteleone P., Bencivenga R., Goossens F., Maj M., van West D., et al. Lower serum activity of prolyl endopeptidase in anorexia and bulimia nervosa. Psychoneuroendocrinology 26 (2001) 17-26
134. Mantella R.C., Vollmer R.R., and Amico J.A. Corticosterone release is heightened in food or water deprived oxytocin deficient male mice. Brain Res 1058 (2005) 56-61
135. Mantella R.C., Vollmer R.R., Li X., and Amico J.A. Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 144 (2003) 2291-2296
136. Martin A., State M., Anderson G.M., Kaye W.M., Hanchett J.M., McConaha C.W., et al. Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report. Biol Psychiatry 44 (1998) 1349-1352
137. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu Rev Neurosci 24 (2001) 1161-1192
138. Meaney M.J., and Szyf M. Maternal care as a model for experience-dependent chromatin plasticity?. Trends Neurosci 28 (2005) 456-463
139. Michelini L.C., Marcelo M.C., Amico J., and Morris M. Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice. Am J Physiol-Heart Circulat Physiol 284 (2003) H2269-H2276
140. Mishima K., Tsukikawa H., Miura I., Inada K., Abe K., Matsumoto Y., et al. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacology 44 (2003) 541-552
141. Mitsui T., Nomura S., Itakura A., and Mizutani S. Role of aminopeptidases in the blood pressure regulation. Biol Pharmacol Bull 27 (2004) 768-771
142. Miura N., Shibata S., and Watanabe S. Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats. Neurosci Lett 196 (1995) 128-130
143. Modahl C., Green L., Fein D., Morris M., Waterhouse L., Feinstein C., et al. Plasma oxytocin levels in autistic children. Biol Psychiatry 43 (1998) 270-277
144. Morgan M.A., Schulkin J., and Pfaff D.W. Estrogens and non-reproductive behaviors related to activity and fear. Neurosci Biobehav Rev 28 (2004) 55-63
145. Murphy J.V., Wheless J.W., and Schmoll C.M. Left vagal nerve stimulation in six patients with hypothalamic hamartomas. Pediatr Neurol 23 (2000) 167-168
146. Nair H.P., and Young L.J. Vasopressin and pair-bond formation: genes to brain to behavior. Physiology (Bethesda) 21 (2006) 146-152
147. Nelson E., and Panksepp J. Oxytocin mediates acquisition of maternally associated odor preferences in pre-weaning rat pups. Behav Neurosci 110 (1996) 583-592
148. Neumann I.D. Alterations in behavioral and neuroendocrine stress coping strategies in pregnant, parturient and lactating rats. In: Russell J.A., Douglas A.J., Windle R.J., and Ingram C.D. (Eds). The maternal brain (2001), Elsevier, New York 143-152
149. Neumann I.D. Brain mechanisms underlying emotional alterations in the peripartum period in rats. Depress Anxiety 17 (2003) 111-121
150. Nomura M., McKenna E., Korach K.S., Pfaff D.W., and Ogawa S. Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res Mol Brain Res 109 (2002) 84-94
151. Nomura M., Saito J., Ueta Y., Muglia L.J., Pfaff D.W., and Ogawa S. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice. J Neuroendocrinol 15 (2003) 1054-1061
152. Noonan L.R., Caldwell J.D., Li L., Walker C.H., Pedersen C.A., and Mason G.A. Neonatal stress transiently alters the development of hippocampal oxytocin receptors. Dev Brain Res 80 (1994) 115-120
153. Olausson H., Uvnas-Moberg K., and Sohlstrom A. Postnatal oxytocin alleviates adverse effects in adult rat offspring caused by maternal malnutrition. Am J Physiol Endocrinol Metab 284 (2003) E475-E480
154. Ostrowski N.L. Oxytocin receptor mRNA expression in rat brain: implications for behavioral integration and reproductive success. Psychoneuroendocrinology 23 (1998) 989-1004
155. Palanza P., Gioiosa L., and Parmigiani S. Social stress in mice: gender differences and effects of estrous cycle and social dominance. Physiol Behav 73 (2001) 411-420
156. Paquin J., Danalache B.A., Jankowski M., McCann S.M., and Gutkowski J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA 99 (2002) 9550-9555
157. Patisaul H.B., Scordalakes E.M., Young L.J., and Rissman E.F. Oxytocin, but not oxytocin receptor, is regulated by oestrogen receptor beta in the female mouse hypothalamus. J Neuroendocrinol 15 (2003) 787-793
158. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 12 (2002) 115-118
159. Pedersen C.A. Oxytocin control of maternal behavior: regulation by sex steroids and offspring stimuli. Ann NY Acad Sci 807 (1997) 126-145
160. Pedersen CA, Boccia ML. Vasopressin interactions with oxytocin in the control of female sexual behavior. Neuroscience; February 17, 2006 [Epub ahead of print].
161. Pedersen C.A., Vadlamudi S.V., Boccia M.L., and Amico J.A. Maternal behavior deficits in nulliparous oxytocin knockout mice. Genes Brain Behav 5 (2006) 274-281
162. Perry E.K., and Perry R.H. Neurochemistry of consciousness: cholinergic pathologies in the human brain. Prog Brain Res 145 (2004) 287-299
163. Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends in Neuroscience; June 27, 2006 [Epub ahead of print].
164. Petersson M. Cardiovascular effects of oxytocin. Prog Brain Res 139 (2002) 281-288
165. Petersson M., Diaz-Cabiale Z., Angel Narvaez J., Fuxe K., and Uvnas-Moberg K. Oxytocin increases the density of high affinity alpha(2)-adrenoceptors within the hypothalamus, the amygdala and the nucleus of the solitary tract in ovariectomized rats. Brain Res 1049 (2005) 234-239
166. Petersson M., Eklund M., and Uvnas-Moberg K. Oxytocin decreases corticosterone and nociception and increases motor activity in OVX rats. Maturitas 51 (2005) 426-433
167. Petersson M., Hulting A.L., and Uvnas-Moberg K. Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci Lett 264 (1999) 41-44
168. Petersson M., Wiberg U., Lundeberg T., and Uvnas-Moberg K. Oxytocin decreases carrageenan induced inflammation in rats. Peptides 22 (2001) 1479-1484
169. Phelps S.M., and Young L.J. Extraordinary diversity in vasopressin (V1a) receptor distributions among wild prairie voles (Microtus ochrogaster): patterns of variation and covariation. J Comp Neurol 466 (2003) 564-576
170. Pinna G., Agis-Balboa R.C., Doueiri M.S., Guidotti A., and Costa E. Brain neurosteroids in gender-related aggression induced by social isolation. Crit Rev Neurobiol 16 (2004) 75-82
171. Pittman Q.J., Chen X., Mouihate A., Hirasawa M., and Martin S. Arginine vasopressin, fever and temperature regulation. Prog Brain Res 119 (1998) 383-392
172. Porges S.W. Love: an emergent property of the mammalian autonomic nervous system. Psychoneuroendocrinology 23 (1998) 837-861
173. Porges S.W. The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol 42 (2001) 123-146
174. Porges S.W. The polyvagal theory: phylogenetic contributions to social behavior. Physiol Behav 79 (2003) 503-513
175. Porges S.W. The vagus: a mediator of behavioral and visceral features associated with autism. In: Bauman M.L., and Kemper T.L. (Eds). The neurobiology of autism (2004), Johns Hopkins University Press, Baltimore 65-78
176. Ragnauth A.K., Devidze N., Moy V., Finley K., Goodwillie A., Kow L.-M., et al. Female oxytocin gene-knockout mice, in a seminatural environment, display exaggerated aggressive behavior. Genes Brain Behav 4 (2005) 229-239
177. Ragnauth A.K., Goodwillie A., Brewer C., Muglia L.J., Pfaff D.W., and Kow L.M. Vasopressin stimulates ventromedial hypothalamic neurons via oxytocin receptors in oxytocin gene knockout male and female mice. Neuroendocrinology 80 (2004) 92-99
178. Ray M.A., Graham A.J., Lee M., Perry R.H., Court J.A., and Perry E.K. Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus. Neurobiol Dis 19 (2005) 366-377
179. Redwine L.S., Altemus M., Leong Y.-M., and Carter C.S. Differential immune responses to stress in postpartum women. Psychoneuroendocrinology 26 (2001) 241-251
180. Ring R.H. The central vasopressinergic system: examining the opportunities for psychiatric drug development. Curr Pharm Design 11 (2005) 205-225
181. Ring R.H., Malberg J.E., Potestio L., Ping J., Boikess S., Luo B., et al. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berlin) 185 (2006) 218-225
182. Rosenblum L.A., Smith E.L., Altemus M., Scharf B.A., Owens M.J., Nemeroff C.B., et al. Differing concentrations of corticotropin-releasing factor and oxytocin in the cerebrospinal fluid of bonnet and pigtail macaques. Psychoneuroendocrinology 27 (2002) 651-660
183. Sawchenko P.E., and Swanson L.W. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205 (1982) 260-272
184. Schumacher M., Coirini H., Johnson A.E., Flanagan L.M., Frankfurt M., Pfaff D.W., et al. The oxytocin receptor: a target for steroid hormones. Regul Pept 45 (1993) 115-119
185. Serradeil-Le Gal C., Wagnon III J., Tonnerre B., Roux R., Garcia G., Griebel G., et al. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev 11 (2005) 53-68
186. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23 (2003) 297-302
187. Singh P.J., and Hofer M.A. Oxytocin reinstates maternal olfactory cues for nipple orientation and attachment in rat pups. Physiol Behav 20 (1978) 385-389
188. Skowsky W.R., Swan L., and Smith P. Effects of sex steroid hormones on arginine vasopressin in intact and castrated male and female rats. Endocrinology 104 (1979) 105-108
189. Skuse D.H. Imprinting, the X-chromosome, and the male brain: explaining sex differences in the liability to autism. Pediatr Res 47 (2000) 9-16
190. Smeltzer M.D., Curtis J.T., Aragona B.J., and Wang Z. Dopamine, oxytocin, and vasopressin receptor binding in the medial prefrontal cortex of monogamous and promiscuous voles. Neurosci Lett 394 (2006) 146-151
191. Snijdewint F.G.M., Van Leeuwen F.W., and Boer G.J. Ontogeny of AVP and OT binding sites in the brain of Wistar and Brattleboro rats as demonstrated by light microscopical autoradiography. J Chem Neuroanat 2 (1989) 3-17
192. Stern J.M., and Lonstein J.S. Neural mediation of nursing and related maternal behaviors. Prog Brain Res 133 (2001) 263-278
193. Stribley J.M., and Carter C.S. Neonatal vasopressin increases aggression in prairie voles. Proc Natl Acad Sci USA 96 (1999) 12601-12604
194. Swaab D.F. Neuropeptides in hypothalamic neuronal disorders. Int Rev Cytol 240 (2004) 305-375
195. Swaab D.F., and Boer G.J. Neuropeptides and brain development: current perils and future potential. J Dev Physiol 5 (1994) 67-75
196. Swaab D.F., Chung W.C., Kruijver F.P., Hofman M.A., and Hestiantoro A. Sex differences in the hypothalamus in the different stages of human life. Neurobiol Aging 24 Suppl 1 (2003) S1-S19
197. Swedo S.E., Leonard H.L., Kruesi M.J., Rettew D.C., Listwak S.J., Berrettini W., et al. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatr 49 (1992) 29-36
198. Takayanagi Y., Yoshida M., Bielsky I.F., Ross H.E., Kawamata M., Onaka T., et al. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci USA 102 (2005) 16096-16101
199. Talebizadeh Z., Bittel D.C., Veatch O.J., Kibiryeva N., and Butler M.G. Brief report: non-random X chromosome inactivation in females with autism. J Autism Dev Disord 35 (2005) 675-681
200. Tanabe S., Shishido Y., Nakayama Y., Furushiro M., Hashimoto S., Terasaki T., et al. Effects of arginine-vasopressin fragment 4-9 on rodent cholinergic systems. Pharmacol Biochem Behav 63 (1999) 549-553
201. Taylor S.E., Klein L.C., Lewis B.P., Gruenewald T.L., Gurung R.A., and Updegraff J.A. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol Rev 107 (2000) 411-429
202. Teicher M.H., Andersen S.L., Polcari A., Anderson C.M., Navlta C.P., and Kim D.M. The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev 27 (2003) 33-44
203. Theodosis D.T., Trailin A., and Poulain D.A. Remodeling of astrocytes, a prerequisite for synapse turnover in the adult brain? Insights from the oxytocin system of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 290 (2006) R1175-R1182
204. Thomas A., Kim N.B., and Amico J.A. Sequential exposure to estrogen and testosterone (T) and subsequent withdrawal of T increases the level of arginine vasopressin messenger ribonucleic acid in the hypothalamic paraventricular nucleus of the female rat. J Neuroendocrinol 8 (1996) 793-800
205. Thompson R., Gupta S., Miller K., Mills S., and Orr S. The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology 29 (2004) 35-48
206. Thompson R.R., George K., Walton J.C., Orr S.P., and Benson J. Sex-specific influences of vasopressin on human social communication. Proc Natl Acad Sci USA 103 (2006) 7889-7894
207. Tordjman S., Ferrari P., Sulmont V., Duyme M., and Roubertoux P. Androgenic activity in autism. Am J Psychiatry 154 (1997) 1626-1627
208. Torres A.R. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders?. BMC Pediatrics 3 (2003) 9-15
209. Toufexis D., Davis C., Hammond A., and Davis M. Sex differences in hormonal modulation of anxiety measured with light-enhanced startle: possible role for arginine vasopressin in the male. J Neurosci 39 (2005) 9010-9016
210. Tribollet E., Charpak S., Schmidt A., Dubois D.M., and Dreifuss J.J. Appearance and transient expression of OT receptors in fetal, infant, peripubertal rat brain studied by autoradiography and electrophysiology. J Neurosci 9 (1989) 1764-1773
211. Tsujimoto M., and Hattori A. The oxytocinase subfamily of M1 aminopeptidases. Biochim Biophys Acta 1751 (2005) 9-18
212. Tueting P, Doueiri MS, Guidotti A, Davis JM, Costa E. Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev; 2006.
213. Uhl-Bronner S., Waltisperger E., Martinez-Lorenzana G., Condes Lara M., and Freund-Mercier M.J. Sexually dimorphic expression of oxytocin binding sites in forebrain and spinal cord of the rat. Neuroscience 135 (2005) 147-154
214. Uvnas-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 23 (1998) 819-835
215. Uvnas-Moberg K. The oxytocin factor (2003), Da Capo Press, Cambridge, MA
216. Vaccari C., Carter C.S., and Ostrowski N.L. Neonatal exposure to arginine AVP alters adult AVP V1a and OT receptor mRNA expression in rat brain. Soc Neurosci Abstr 22 (1996) 81
217. Valicenti-McDermott M., McVicar K., Rapin I., Wershil B.K., Cohen H., and Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 27 (2006) S128-S136
218. Van Londen L., Goekoop J.G., Van Kempen G.M.J., Frankhuijzen-Sierevogel A.C., Wiegant V.M., Van der Velde E.A., et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 17 (1997) 284-292
219. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005) 67-81
220. Wang Z., Hulihan T.J., and Insel T.R. Sexual and social experience is associated with different patterns of behavior and neural activation in male prairie voles. Brain Res 767 (1997) 321-332
221. Wang Z., Young L.J., De Vries G.J., and Insel T.R. Voles and vasopressin: a review of molecular, cellular, and behavioral studies of pair bonding and paternal behaviors. Prog Brain Res 119 (1998) 483-499
222. Wang Z., Young L.J., Liu Y., and Insel T.R. Species differences in AVP receptor binding are evident early in development: comparative anatomic studies in prairie and montane voles. J Comp Neurol 378 (1997) 535-546
223. Wassink T.H., Piven J., Vieland V.J., Pietilla J., Goedkern R.J., Flostein S.E., et al. Examination of the AVPR1a as an autism susceptibility gene. Mol Psychiatry 9 (2004) 8-972
224. Weaver I.C., Champagne F.A., Brown S.E., Dymov S., Sharma S., Meaney M.J., et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25 (2006) 11045-11054
225. Welch M.G., and Ruggiero D.A. Predicted role of secretin and oxytocin in the treatment of behavioral and developmental disorders: implications for autism. Int Rev Neurobiol 71 (2005) 273-314
226. Welch M.G., Welch-Horan T.B., Anwar M., Anwar N., Ludwig R.J., and Ruggiero D.A. Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin. J Mol Neurosci 25 (2005) 259-274
227. Wetherby A.M., Woods J., Allen L., Cleary J., Dickinson H., and Lord C.J. Early indicators of autism spectrum disorders in the second year of life. Autism Dev Disorders 34 (2004) 473-493
228. Williams J.R., Insel T.R., Harbaugh C.R., and Carter C.S. Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles. J Neuroendocrinol 6 (1994) 247-250
229. Winslow J.T. Neuropeptides and non-human primate social deficits associated with pathogenic rearing experience. Int J Dev Neurosci 23 (2005) 245-251
230. Winslow J.T., Hastings N., Carter C.S., Harbaugh C.R., and Insel T.R. A role for central vasopressin in pair bonding in monogamous priarie voles. Nature 365 (1993) 545-548
231. Winslow J.T., and Insel T.R. The social deficits of the oxytocin knockout mouse. Neuropeptides 36 (2002) 221-229
232. Winslow J.T., Noble P.L., Lyons C.K., Sterk S.M., and Insel T.R. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology 28 (2003) 910-918
233. Witt D.M. Mechanisms of oxytocin-mediated sociosexual behavior. Ann NY Acad Sci 807 (1997) 287-301
234. Witt D.M., Carter C.S., and Insel T.R. Oxytocin receptor binding in female prairie voles: endogenous and exogenous oestradiol stimulation. J Neuroendocrinol 3 (1991) 155-161
235. Wu S., Jian M., Ruan Y., Liu J., Guo Y., Shuang M., et al. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol Psychiatry 58 (2005) 75-77
236. Yamamoto Y., Carter C.S., and Cushing B.S. Neonatal manipulation of oxytocin affects expression of estrogen receptor alpha. Neuroscience 137 (2005) 157-164
237. Yamamoto Y., Cushing B.S., Kramer K.M., Epperson P.D., Hoffman G.E., and Carter C.S. Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience 125 (2004) 947-955
238. Ylisaukko-oja T., Alarcon M., Cantor R.M., Auranen M., Vanhala R., Kempas E., et al. Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families. Ann Neurobiol 59 (2006) 145-155
239. 1a receptor from a monogamous vole. Nature 400 (1999) 766-768
240. Young L.J., Pitkow L.J., and Ferguson J.N. Neuropeptides and social behavior: animal models relevant to autism. Mol Psychiatry 7 (2002) S38-S39
241. Young L.J., Winslow J.T., Nilsen R., and Insel T.R. Species differences in V1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences. Behav Neurosci 111 (1997) 599-605
242. Zhao L., and Brinton R.D. Suppression of proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha in astrocytes by a V1 vasopressin receptor agonist: a cAMP response element-binding protein-dependent mechanism. J Neurosci 24 (2004) 2226-2235
243. Zhou L., Blaustein J.D., and De Vries G.J. Distribution of androgen receptor immunoreactivity in vasopressin- and oxytocin-immunoreactive neurons in the male rat brain. Endocrinology 134 (1994) 2622-2627
244. Zingg H.H. Oxytocin. In: Pfaff D., et al. (Ed). Hormones, brain and behavior vol. III (2002), Academic Press, San Diego 779-802
245. Zingg H.H., and Laporte S.A. The oxytocin receptor. Trends Endocrinol Metab 14 (2003) 222-227